Molecular subtyping to predict better clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine with or without trastuzumab.
Stefan Gluck
Consultant or Advisory Role - Agendia
Melanie Royce
No relevant relationships to disclose
Lisette Stork-Sloots
Employment or Leadership Position - Agendia
Femke De Snoo
Employment or Leadership Position - Agendia